Yiran Gan 4/4/25 Yiran Gan 4/4/25 The contribution of vascular risk factors in neurodegenerative disorders: from mild cognitive impairment to Alzheimer’s disease Read More Yiran Gan 4/4/25 Yiran Gan 4/4/25 Development of an assay of plasma neurofilament light chain utilizing immunomagnetic reduction technology Read More Yiran Gan 4/4/25 Yiran Gan 4/4/25 Structure, Magnetic Property, Surface Morphology, and Surface Energy of Co40Fe40V10B10 Films on Si(100) Substrate Read More Yiran Gan 4/4/25 Yiran Gan 4/4/25 Plasma pyroglutamate‐modified amyloid beta differentiates amyloid pathology Read More Yiran Gan 4/4/25 Yiran Gan 4/4/25 Plasma Levels of α-Synuclein, Aβ-40 and T-tau as Biomarkers to Predict Cognitive Impairment in Parkinson’s Disease Read More Yiran Gan 4/4/25 Yiran Gan 4/4/25 Stability of Plasma Amyloid-β 1–40, Amyloid-β 1–42, and Total Tau Protein over Repeated Freeze/Thaw Cycles Read More Yiran Gan 4/4/25 Yiran Gan 4/4/25 Frontal variant of Alzheimer's disease with asymmetric presentation mimicking frontotemporal dementia: Case report and literature review Read More Yiran Gan 4/4/25 Yiran Gan 4/4/25 Composite Scores of Plasma Tau and β-Amyloids Correlate with Dementia in Down Syndrome Read More Yiran Gan 4/4/25 Yiran Gan 4/4/25 Plasma and Serum Alpha-Synuclein as a Biomarker of Diagnosis in Patients With Parkinson's Disease Read More Yiran Gan 4/4/25 Yiran Gan 4/4/25 Integrated Plasma and Neuroimaging Biomarkers Associated with Motor and Cognition Severity in Parkinson’s Disease Read More Newer Posts Older Posts
Yiran Gan 4/4/25 Yiran Gan 4/4/25 The contribution of vascular risk factors in neurodegenerative disorders: from mild cognitive impairment to Alzheimer’s disease Read More
Yiran Gan 4/4/25 Yiran Gan 4/4/25 Development of an assay of plasma neurofilament light chain utilizing immunomagnetic reduction technology Read More
Yiran Gan 4/4/25 Yiran Gan 4/4/25 Structure, Magnetic Property, Surface Morphology, and Surface Energy of Co40Fe40V10B10 Films on Si(100) Substrate Read More
Yiran Gan 4/4/25 Yiran Gan 4/4/25 Plasma pyroglutamate‐modified amyloid beta differentiates amyloid pathology Read More
Yiran Gan 4/4/25 Yiran Gan 4/4/25 Plasma Levels of α-Synuclein, Aβ-40 and T-tau as Biomarkers to Predict Cognitive Impairment in Parkinson’s Disease Read More
Yiran Gan 4/4/25 Yiran Gan 4/4/25 Stability of Plasma Amyloid-β 1–40, Amyloid-β 1–42, and Total Tau Protein over Repeated Freeze/Thaw Cycles Read More
Yiran Gan 4/4/25 Yiran Gan 4/4/25 Frontal variant of Alzheimer's disease with asymmetric presentation mimicking frontotemporal dementia: Case report and literature review Read More
Yiran Gan 4/4/25 Yiran Gan 4/4/25 Composite Scores of Plasma Tau and β-Amyloids Correlate with Dementia in Down Syndrome Read More
Yiran Gan 4/4/25 Yiran Gan 4/4/25 Plasma and Serum Alpha-Synuclein as a Biomarker of Diagnosis in Patients With Parkinson's Disease Read More
Yiran Gan 4/4/25 Yiran Gan 4/4/25 Integrated Plasma and Neuroimaging Biomarkers Associated with Motor and Cognition Severity in Parkinson’s Disease Read More
